Precision Oncology
AI genomics company Freenome announced a partnership with proteomics firm Biognosys in order to enhance its broad-signal approach to early-cancer […]
AI genomics company Freenome announced a partnership with proteomics firm Biognosys in order to enhance its broad-signal approach to early-cancer […]
Precision medicine was a key topic at this year’s Analytica conference from April 10-13 in Munich, Germany. Experts from associations,
An artificial vision device for people who are blind or visually impaired, OrCam MyEye 2.0 improves the user’s vision using